nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesalazine—MPO—Carboplatin—brain cancer	0.308	0.652	CbGbCtD
Mesalazine—PTGS2—Etoposide—brain cancer	0.0892	0.189	CbGbCtD
Mesalazine—PTGS1—Etoposide—brain cancer	0.0753	0.16	CbGbCtD
Mesalazine—PPARG—Teniposide—Etoposide—brain cancer	0.00441	1	CbGdCrCtD
Mesalazine—MPO—endothelium—brain cancer	0.00354	0.0553	CbGeAlD
Mesalazine—MPO—blood vessel—brain cancer	0.00327	0.051	CbGeAlD
Mesalazine—PPARG—endothelium—brain cancer	0.00314	0.0491	CbGeAlD
Mesalazine—PPARG—blood vessel—brain cancer	0.0029	0.0453	CbGeAlD
Mesalazine—IKBKB—telencephalon—brain cancer	0.00226	0.0353	CbGeAlD
Mesalazine—CHUK—endocrine gland—brain cancer	0.0021	0.0327	CbGeAlD
Mesalazine—CHUK—head—brain cancer	0.00207	0.0323	CbGeAlD
Mesalazine—PTGS1—ganglion—brain cancer	0.00195	0.0304	CbGeAlD
Mesalazine—IKBKB—gonad—brain cancer	0.00189	0.0295	CbGeAlD
Mesalazine—CHUK—cerebellum—brain cancer	0.00185	0.0288	CbGeAlD
Mesalazine—IKBKB—pituitary gland—brain cancer	0.00184	0.0287	CbGeAlD
Mesalazine—PTGS1—endothelium—brain cancer	0.00168	0.0262	CbGeAlD
Mesalazine—PTGS2—endothelium—brain cancer	0.00161	0.0251	CbGeAlD
Mesalazine—PTGS1—blood vessel—brain cancer	0.00155	0.0242	CbGeAlD
Mesalazine—CHUK—brain—brain cancer	0.0015	0.0234	CbGeAlD
Mesalazine—PTGS2—blood vessel—brain cancer	0.00148	0.0231	CbGeAlD
Mesalazine—IKBKB—endocrine gland—brain cancer	0.00142	0.0223	CbGeAlD
Mesalazine—IKBKB—head—brain cancer	0.00141	0.022	CbGeAlD
Mesalazine—MPO—pituitary gland—brain cancer	0.00129	0.0202	CbGeAlD
Mesalazine—IKBKB—central nervous system—brain cancer	0.00128	0.0201	CbGeAlD
Mesalazine—IKBKB—cerebellum—brain cancer	0.00126	0.0196	CbGeAlD
Mesalazine—ALOX5—endocrine gland—brain cancer	0.00118	0.0184	CbGeAlD
Mesalazine—ALOX5—head—brain cancer	0.00117	0.0182	CbGeAlD
Mesalazine—MPO—spinal cord—brain cancer	0.00111	0.0173	CbGeAlD
Mesalazine—ALOX5—central nervous system—brain cancer	0.00106	0.0166	CbGeAlD
Mesalazine—ALOX5—cerebellum—brain cancer	0.00104	0.0163	CbGeAlD
Mesalazine—IKBKB—brain—brain cancer	0.00102	0.0159	CbGeAlD
Mesalazine—MPO—endocrine gland—brain cancer	0.000999	0.0156	CbGeAlD
Mesalazine—MPO—head—brain cancer	0.000986	0.0154	CbGeAlD
Mesalazine—MPO—central nervous system—brain cancer	0.0009	0.0141	CbGeAlD
Mesalazine—PPARG—endocrine gland—brain cancer	0.000887	0.0139	CbGeAlD
Mesalazine—PPARG—head—brain cancer	0.000875	0.0137	CbGeAlD
Mesalazine—ALOX5—brain—brain cancer	0.000845	0.0132	CbGeAlD
Mesalazine—Salicylic acid—CYP2C9—brain cancer	0.000816	0.546	CrCbGaD
Mesalazine—PPARG—central nervous system—brain cancer	0.000799	0.0125	CbGeAlD
Mesalazine—PTGS1—telencephalon—brain cancer	0.000752	0.0117	CbGeAlD
Mesalazine—PTGS2—telencephalon—brain cancer	0.000718	0.0112	CbGeAlD
Mesalazine—MPO—brain—brain cancer	0.000715	0.0112	CbGeAlD
Mesalazine—Dopamine—CYP2C9—brain cancer	0.000679	0.454	CrCbGaD
Mesalazine—PPARG—brain—brain cancer	0.000634	0.00991	CbGeAlD
Mesalazine—PTGS1—pituitary gland—brain cancer	0.000612	0.00956	CbGeAlD
Mesalazine—PTGS2—pituitary gland—brain cancer	0.000585	0.00914	CbGeAlD
Mesalazine—PTGS2—medulla oblongata—brain cancer	0.000564	0.00882	CbGeAlD
Mesalazine—PTGS1—spinal cord—brain cancer	0.000527	0.00823	CbGeAlD
Mesalazine—PTGS2—midbrain—brain cancer	0.000516	0.00806	CbGeAlD
Mesalazine—PTGS2—spinal cord—brain cancer	0.000503	0.00786	CbGeAlD
Mesalazine—PTGS1—endocrine gland—brain cancer	0.000474	0.00741	CbGeAlD
Mesalazine—PTGS1—head—brain cancer	0.000468	0.00731	CbGeAlD
Mesalazine—PTGS2—endocrine gland—brain cancer	0.000453	0.00708	CbGeAlD
Mesalazine—PTGS2—head—brain cancer	0.000447	0.00699	CbGeAlD
Mesalazine—PTGS1—central nervous system—brain cancer	0.000427	0.00667	CbGeAlD
Mesalazine—PTGS2—central nervous system—brain cancer	0.000408	0.00638	CbGeAlD
Mesalazine—PTGS2—cerebellum—brain cancer	0.000399	0.00623	CbGeAlD
Mesalazine—Neuropathy peripheral—Temozolomide—brain cancer	0.000373	0.0013	CcSEcCtD
Mesalazine—Stomatitis—Temozolomide—brain cancer	0.000371	0.00129	CcSEcCtD
Mesalazine—Urinary tract infection—Temozolomide—brain cancer	0.00037	0.00129	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000366	0.00128	CcSEcCtD
Mesalazine—Insomnia—Procarbazine—brain cancer	0.000363	0.00127	CcSEcCtD
Mesalazine—Paraesthesia—Procarbazine—brain cancer	0.00036	0.00126	CcSEcCtD
Mesalazine—Hepatobiliary disease—Temozolomide—brain cancer	0.00036	0.00126	CcSEcCtD
Mesalazine—Sinusitis—Temozolomide—brain cancer	0.000357	0.00125	CcSEcCtD
Mesalazine—Somnolence—Procarbazine—brain cancer	0.000357	0.00125	CcSEcCtD
Mesalazine—Cramp muscle—Etoposide—brain cancer	0.000356	0.00124	CcSEcCtD
Mesalazine—Haemoglobin—Carmustine—brain cancer	0.000355	0.00124	CcSEcCtD
Mesalazine—Haemorrhage—Carmustine—brain cancer	0.000353	0.00123	CcSEcCtD
Mesalazine—Ill-defined disorder—Hydroxyurea—brain cancer	0.000353	0.00123	CcSEcCtD
Mesalazine—Anaemia—Hydroxyurea—brain cancer	0.000352	0.00123	CcSEcCtD
Mesalazine—Decreased appetite—Procarbazine—brain cancer	0.000349	0.00122	CcSEcCtD
Mesalazine—Alanine aminotransferase increased—Etoposide—brain cancer	0.000348	0.00122	CcSEcCtD
Mesalazine—Oedema peripheral—Carmustine—brain cancer	0.000348	0.00122	CcSEcCtD
Mesalazine—Connective tissue disorder—Carmustine—brain cancer	0.000347	0.00121	CcSEcCtD
Mesalazine—Fatigue—Procarbazine—brain cancer	0.000346	0.00121	CcSEcCtD
Mesalazine—Haemoglobin—Temozolomide—brain cancer	0.000343	0.0012	CcSEcCtD
Mesalazine—Malaise—Hydroxyurea—brain cancer	0.000343	0.0012	CcSEcCtD
Mesalazine—Pain—Procarbazine—brain cancer	0.000343	0.0012	CcSEcCtD
Mesalazine—Constipation—Procarbazine—brain cancer	0.000343	0.0012	CcSEcCtD
Mesalazine—Hepatitis—Temozolomide—brain cancer	0.000341	0.00119	CcSEcCtD
Mesalazine—Haemorrhage—Temozolomide—brain cancer	0.000341	0.00119	CcSEcCtD
Mesalazine—Dysphagia—Etoposide—brain cancer	0.000341	0.00119	CcSEcCtD
Mesalazine—Leukopenia—Hydroxyurea—brain cancer	0.000341	0.00119	CcSEcCtD
Mesalazine—PTGS1—brain—brain cancer	0.000339	0.0053	CbGeAlD
Mesalazine—Pharyngitis—Temozolomide—brain cancer	0.000339	0.00118	CcSEcCtD
Mesalazine—Urinary tract disorder—Temozolomide—brain cancer	0.000337	0.00118	CcSEcCtD
Mesalazine—Oedema peripheral—Temozolomide—brain cancer	0.000336	0.00117	CcSEcCtD
Mesalazine—Bronchospasm—Etoposide—brain cancer	0.000336	0.00117	CcSEcCtD
Mesalazine—Connective tissue disorder—Temozolomide—brain cancer	0.000336	0.00117	CcSEcCtD
Mesalazine—Urethral disorder—Temozolomide—brain cancer	0.000335	0.00117	CcSEcCtD
Mesalazine—Feeling abnormal—Procarbazine—brain cancer	0.000331	0.00115	CcSEcCtD
Mesalazine—Eye disorder—Carmustine—brain cancer	0.00033	0.00115	CcSEcCtD
Mesalazine—Gastrointestinal pain—Procarbazine—brain cancer	0.000328	0.00115	CcSEcCtD
Mesalazine—Pancytopenia—Etoposide—brain cancer	0.000324	0.00113	CcSEcCtD
Mesalazine—PTGS2—brain—brain cancer	0.000324	0.00506	CbGeAlD
Mesalazine—Erythema multiforme—Temozolomide—brain cancer	0.000323	0.00113	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000322	0.00112	CcSEcCtD
Mesalazine—Discomfort—Hydroxyurea—brain cancer	0.00032	0.00112	CcSEcCtD
Mesalazine—Neutropenia—Etoposide—brain cancer	0.000319	0.00111	CcSEcCtD
Mesalazine—Eye disorder—Temozolomide—brain cancer	0.000319	0.00111	CcSEcCtD
Mesalazine—Urticaria—Procarbazine—brain cancer	0.000319	0.00111	CcSEcCtD
Mesalazine—Tinnitus—Temozolomide—brain cancer	0.000318	0.00111	CcSEcCtD
Mesalazine—Abdominal pain—Procarbazine—brain cancer	0.000317	0.00111	CcSEcCtD
Mesalazine—Body temperature increased—Procarbazine—brain cancer	0.000317	0.00111	CcSEcCtD
Mesalazine—Cardiac disorder—Temozolomide—brain cancer	0.000317	0.00111	CcSEcCtD
Mesalazine—Alopecia—Carmustine—brain cancer	0.000312	0.00109	CcSEcCtD
Mesalazine—Oedema—Hydroxyurea—brain cancer	0.000311	0.00108	CcSEcCtD
Mesalazine—Angiopathy—Temozolomide—brain cancer	0.00031	0.00108	CcSEcCtD
Mesalazine—Mental disorder—Carmustine—brain cancer	0.00031	0.00108	CcSEcCtD
Mesalazine—Infection—Hydroxyurea—brain cancer	0.000308	0.00108	CcSEcCtD
Mesalazine—Immune system disorder—Temozolomide—brain cancer	0.000308	0.00108	CcSEcCtD
Mesalazine—Mediastinal disorder—Temozolomide—brain cancer	0.000308	0.00107	CcSEcCtD
Mesalazine—Erythema—Carmustine—brain cancer	0.000308	0.00107	CcSEcCtD
Mesalazine—Chills—Temozolomide—brain cancer	0.000306	0.00107	CcSEcCtD
Mesalazine—Pneumonia—Etoposide—brain cancer	0.000306	0.00107	CcSEcCtD
Mesalazine—Nervous system disorder—Hydroxyurea—brain cancer	0.000305	0.00106	CcSEcCtD
Mesalazine—Infestation NOS—Etoposide—brain cancer	0.000304	0.00106	CcSEcCtD
Mesalazine—Infestation—Etoposide—brain cancer	0.000304	0.00106	CcSEcCtD
Mesalazine—Thrombocytopenia—Hydroxyurea—brain cancer	0.000304	0.00106	CcSEcCtD
Mesalazine—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000302	0.00105	CcSEcCtD
Mesalazine—Alopecia—Temozolomide—brain cancer	0.000302	0.00105	CcSEcCtD
Mesalazine—Skin disorder—Hydroxyurea—brain cancer	0.000302	0.00105	CcSEcCtD
Mesalazine—Renal failure—Etoposide—brain cancer	0.000299	0.00104	CcSEcCtD
Mesalazine—Mental disorder—Temozolomide—brain cancer	0.000299	0.00104	CcSEcCtD
Mesalazine—Neuropathy peripheral—Etoposide—brain cancer	0.000298	0.00104	CcSEcCtD
Mesalazine—Back pain—Carmustine—brain cancer	0.000298	0.00104	CcSEcCtD
Mesalazine—Erythema—Temozolomide—brain cancer	0.000297	0.00104	CcSEcCtD
Mesalazine—Jaundice—Etoposide—brain cancer	0.000297	0.00104	CcSEcCtD
Mesalazine—Stomatitis—Etoposide—brain cancer	0.000297	0.00104	CcSEcCtD
Mesalazine—Anorexia—Hydroxyurea—brain cancer	0.000296	0.00103	CcSEcCtD
Mesalazine—Hypersensitivity—Procarbazine—brain cancer	0.000296	0.00103	CcSEcCtD
Mesalazine—Dysgeusia—Temozolomide—brain cancer	0.000291	0.00102	CcSEcCtD
Mesalazine—Vision blurred—Carmustine—brain cancer	0.00029	0.00101	CcSEcCtD
Mesalazine—Tremor—Carmustine—brain cancer	0.000288	0.00101	CcSEcCtD
Mesalazine—Asthenia—Procarbazine—brain cancer	0.000288	0.00101	CcSEcCtD
Mesalazine—Hepatobiliary disease—Etoposide—brain cancer	0.000288	0.00101	CcSEcCtD
Mesalazine—Back pain—Temozolomide—brain cancer	0.000287	0.001	CcSEcCtD
Mesalazine—Anaemia—Carmustine—brain cancer	0.000284	0.000993	CcSEcCtD
Mesalazine—Agranulocytosis—Etoposide—brain cancer	0.000284	0.000992	CcSEcCtD
Mesalazine—Pruritus—Procarbazine—brain cancer	0.000284	0.000991	CcSEcCtD
Mesalazine—Vision blurred—Temozolomide—brain cancer	0.00028	0.000978	CcSEcCtD
Mesalazine—Tremor—Temozolomide—brain cancer	0.000278	0.000972	CcSEcCtD
Mesalazine—Dyspnoea—Hydroxyurea—brain cancer	0.000277	0.000967	CcSEcCtD
Mesalazine—Somnolence—Hydroxyurea—brain cancer	0.000276	0.000964	CcSEcCtD
Mesalazine—Ill-defined disorder—Temozolomide—brain cancer	0.000276	0.000963	CcSEcCtD
Mesalazine—Leukopenia—Carmustine—brain cancer	0.000275	0.000961	CcSEcCtD
Mesalazine—Anaemia—Temozolomide—brain cancer	0.000275	0.000959	CcSEcCtD
Mesalazine—Diarrhoea—Procarbazine—brain cancer	0.000275	0.000958	CcSEcCtD
Mesalazine—Dyspepsia—Hydroxyurea—brain cancer	0.000273	0.000954	CcSEcCtD
Mesalazine—Angioedema—Temozolomide—brain cancer	0.000272	0.000948	CcSEcCtD
Mesalazine—Decreased appetite—Hydroxyurea—brain cancer	0.00027	0.000942	CcSEcCtD
Mesalazine—Urinary tract disorder—Etoposide—brain cancer	0.00027	0.000942	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000268	0.000936	CcSEcCtD
Mesalazine—Malaise—Temozolomide—brain cancer	0.000268	0.000936	CcSEcCtD
Mesalazine—Urethral disorder—Etoposide—brain cancer	0.000268	0.000935	CcSEcCtD
Mesalazine—Fatigue—Hydroxyurea—brain cancer	0.000268	0.000935	CcSEcCtD
Mesalazine—Vertigo—Temozolomide—brain cancer	0.000267	0.000932	CcSEcCtD
Mesalazine—Leukopenia—Temozolomide—brain cancer	0.000266	0.000929	CcSEcCtD
Mesalazine—Hypertension—Carmustine—brain cancer	0.000266	0.000927	CcSEcCtD
Mesalazine—Pain—Hydroxyurea—brain cancer	0.000266	0.000927	CcSEcCtD
Mesalazine—Constipation—Hydroxyurea—brain cancer	0.000266	0.000927	CcSEcCtD
Mesalazine—Dizziness—Procarbazine—brain cancer	0.000265	0.000926	CcSEcCtD
Mesalazine—Palpitations—Temozolomide—brain cancer	0.000263	0.000917	CcSEcCtD
Mesalazine—Myalgia—Carmustine—brain cancer	0.000262	0.000914	CcSEcCtD
Mesalazine—Chest pain—Carmustine—brain cancer	0.000262	0.000914	CcSEcCtD
Mesalazine—Anxiety—Carmustine—brain cancer	0.000261	0.000911	CcSEcCtD
Mesalazine—Cough—Temozolomide—brain cancer	0.000259	0.000906	CcSEcCtD
Mesalazine—Erythema multiforme—Etoposide—brain cancer	0.000258	0.000902	CcSEcCtD
Mesalazine—Hypertension—Temozolomide—brain cancer	0.000257	0.000896	CcSEcCtD
Mesalazine—Feeling abnormal—Hydroxyurea—brain cancer	0.000256	0.000893	CcSEcCtD
Mesalazine—Eye disorder—Etoposide—brain cancer	0.000255	0.000891	CcSEcCtD
Mesalazine—Vomiting—Procarbazine—brain cancer	0.000255	0.000891	CcSEcCtD
Mesalazine—Cardiac disorder—Etoposide—brain cancer	0.000254	0.000885	CcSEcCtD
Mesalazine—Confusional state—Carmustine—brain cancer	0.000253	0.000884	CcSEcCtD
Mesalazine—Myalgia—Temozolomide—brain cancer	0.000253	0.000884	CcSEcCtD
Mesalazine—Arthralgia—Temozolomide—brain cancer	0.000253	0.000884	CcSEcCtD
Mesalazine—Rash—Procarbazine—brain cancer	0.000253	0.000883	CcSEcCtD
Mesalazine—Dermatitis—Procarbazine—brain cancer	0.000253	0.000882	CcSEcCtD
Mesalazine—Anxiety—Temozolomide—brain cancer	0.000252	0.00088	CcSEcCtD
Mesalazine—Headache—Procarbazine—brain cancer	0.000251	0.000878	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000251	0.000877	CcSEcCtD
Mesalazine—Oedema—Carmustine—brain cancer	0.000251	0.000876	CcSEcCtD
Mesalazine—Discomfort—Temozolomide—brain cancer	0.00025	0.000873	CcSEcCtD
Mesalazine—Infection—Carmustine—brain cancer	0.000249	0.000871	CcSEcCtD
Mesalazine—Angiopathy—Etoposide—brain cancer	0.000248	0.000866	CcSEcCtD
Mesalazine—Dry mouth—Temozolomide—brain cancer	0.000247	0.000864	CcSEcCtD
Mesalazine—Immune system disorder—Etoposide—brain cancer	0.000247	0.000862	CcSEcCtD
Mesalazine—Mediastinal disorder—Etoposide—brain cancer	0.000246	0.00086	CcSEcCtD
Mesalazine—Thrombocytopenia—Carmustine—brain cancer	0.000246	0.000858	CcSEcCtD
Mesalazine—Body temperature increased—Hydroxyurea—brain cancer	0.000245	0.000857	CcSEcCtD
Mesalazine—Chills—Etoposide—brain cancer	0.000245	0.000856	CcSEcCtD
Mesalazine—Tachycardia—Carmustine—brain cancer	0.000245	0.000855	CcSEcCtD
Mesalazine—Confusional state—Temozolomide—brain cancer	0.000245	0.000854	CcSEcCtD
Mesalazine—Anaphylactic shock—Temozolomide—brain cancer	0.000243	0.000847	CcSEcCtD
Mesalazine—Oedema—Temozolomide—brain cancer	0.000243	0.000847	CcSEcCtD
Mesalazine—Alopecia—Etoposide—brain cancer	0.000241	0.000843	CcSEcCtD
Mesalazine—Infection—Temozolomide—brain cancer	0.000241	0.000841	CcSEcCtD
Mesalazine—Anorexia—Carmustine—brain cancer	0.000239	0.000835	CcSEcCtD
Mesalazine—Nausea—Procarbazine—brain cancer	0.000238	0.000832	CcSEcCtD
Mesalazine—Nervous system disorder—Temozolomide—brain cancer	0.000238	0.000831	CcSEcCtD
Mesalazine—Thrombocytopenia—Temozolomide—brain cancer	0.000238	0.000829	CcSEcCtD
Mesalazine—Skin disorder—Temozolomide—brain cancer	0.000236	0.000823	CcSEcCtD
Mesalazine—Hypotension—Carmustine—brain cancer	0.000235	0.000819	CcSEcCtD
Mesalazine—Hyperhidrosis—Temozolomide—brain cancer	0.000234	0.000819	CcSEcCtD
Mesalazine—Dysgeusia—Etoposide—brain cancer	0.000233	0.000813	CcSEcCtD
Mesalazine—Anorexia—Temozolomide—brain cancer	0.000231	0.000807	CcSEcCtD
Mesalazine—Back pain—Etoposide—brain cancer	0.00023	0.000803	CcSEcCtD
Mesalazine—Hypersensitivity—Hydroxyurea—brain cancer	0.000229	0.000799	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Carmustine—brain cancer	0.000229	0.000799	CcSEcCtD
Mesalazine—Muscle spasms—Etoposide—brain cancer	0.000229	0.000798	CcSEcCtD
Mesalazine—Insomnia—Carmustine—brain cancer	0.000227	0.000793	CcSEcCtD
Mesalazine—Paraesthesia—Carmustine—brain cancer	0.000225	0.000787	CcSEcCtD
Mesalazine—Dyspnoea—Carmustine—brain cancer	0.000224	0.000781	CcSEcCtD
Mesalazine—Somnolence—Carmustine—brain cancer	0.000223	0.000779	CcSEcCtD
Mesalazine—Asthenia—Hydroxyurea—brain cancer	0.000223	0.000778	CcSEcCtD
Mesalazine—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000221	0.000772	CcSEcCtD
Mesalazine—Ill-defined disorder—Etoposide—brain cancer	0.000221	0.000771	CcSEcCtD
Mesalazine—Anaemia—Etoposide—brain cancer	0.00022	0.000768	CcSEcCtD
Mesalazine—Insomnia—Temozolomide—brain cancer	0.000219	0.000766	CcSEcCtD
Mesalazine—Decreased appetite—Carmustine—brain cancer	0.000218	0.000762	CcSEcCtD
Mesalazine—Paraesthesia—Temozolomide—brain cancer	0.000218	0.000761	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Carmustine—brain cancer	0.000217	0.000757	CcSEcCtD
Mesalazine—Dyspnoea—Temozolomide—brain cancer	0.000216	0.000755	CcSEcCtD
Mesalazine—Somnolence—Temozolomide—brain cancer	0.000216	0.000753	CcSEcCtD
Mesalazine—Constipation—Carmustine—brain cancer	0.000215	0.000749	CcSEcCtD
Mesalazine—Pain—Carmustine—brain cancer	0.000215	0.000749	CcSEcCtD
Mesalazine—Malaise—Etoposide—brain cancer	0.000214	0.000749	CcSEcCtD
Mesalazine—Vertigo—Etoposide—brain cancer	0.000214	0.000746	CcSEcCtD
Mesalazine—Dyspepsia—Temozolomide—brain cancer	0.000214	0.000746	CcSEcCtD
Mesalazine—Leukopenia—Etoposide—brain cancer	0.000213	0.000743	CcSEcCtD
Mesalazine—Diarrhoea—Hydroxyurea—brain cancer	0.000212	0.000742	CcSEcCtD
Mesalazine—Decreased appetite—Temozolomide—brain cancer	0.000211	0.000736	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Temozolomide—brain cancer	0.000209	0.000731	CcSEcCtD
Mesalazine—Fatigue—Temozolomide—brain cancer	0.000209	0.00073	CcSEcCtD
Mesalazine—Loss of consciousness—Etoposide—brain cancer	0.000209	0.00073	CcSEcCtD
Mesalazine—Cough—Etoposide—brain cancer	0.000208	0.000725	CcSEcCtD
Mesalazine—Pain—Temozolomide—brain cancer	0.000207	0.000724	CcSEcCtD
Mesalazine—Constipation—Temozolomide—brain cancer	0.000207	0.000724	CcSEcCtD
Mesalazine—Feeling abnormal—Carmustine—brain cancer	0.000207	0.000722	CcSEcCtD
Mesalazine—Hypertension—Etoposide—brain cancer	0.000205	0.000717	CcSEcCtD
Mesalazine—Dizziness—Hydroxyurea—brain cancer	0.000205	0.000717	CcSEcCtD
Mesalazine—Gastrointestinal pain—Carmustine—brain cancer	0.000205	0.000717	CcSEcCtD
Mesalazine—Chest pain—Etoposide—brain cancer	0.000202	0.000707	CcSEcCtD
Mesalazine—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000201	0.000702	CcSEcCtD
Mesalazine—Discomfort—Etoposide—brain cancer	0.0002	0.000699	CcSEcCtD
Mesalazine—Feeling abnormal—Temozolomide—brain cancer	0.0002	0.000698	CcSEcCtD
Mesalazine—Abdominal pain—Carmustine—brain cancer	0.000198	0.000693	CcSEcCtD
Mesalazine—Body temperature increased—Carmustine—brain cancer	0.000198	0.000693	CcSEcCtD
Mesalazine—Gastrointestinal pain—Temozolomide—brain cancer	0.000198	0.000693	CcSEcCtD
Mesalazine—Vomiting—Hydroxyurea—brain cancer	0.000197	0.000689	CcSEcCtD
Mesalazine—Rash—Hydroxyurea—brain cancer	0.000196	0.000684	CcSEcCtD
Mesalazine—Confusional state—Etoposide—brain cancer	0.000196	0.000683	CcSEcCtD
Mesalazine—Dermatitis—Hydroxyurea—brain cancer	0.000196	0.000683	CcSEcCtD
Mesalazine—Headache—Hydroxyurea—brain cancer	0.000195	0.000679	CcSEcCtD
Mesalazine—Anaphylactic shock—Etoposide—brain cancer	0.000194	0.000678	CcSEcCtD
Mesalazine—Infection—Etoposide—brain cancer	0.000193	0.000673	CcSEcCtD
Mesalazine—Urticaria—Temozolomide—brain cancer	0.000193	0.000673	CcSEcCtD
Mesalazine—Abdominal pain—Temozolomide—brain cancer	0.000192	0.00067	CcSEcCtD
Mesalazine—Body temperature increased—Temozolomide—brain cancer	0.000192	0.00067	CcSEcCtD
Mesalazine—Thrombocytopenia—Etoposide—brain cancer	0.00019	0.000664	CcSEcCtD
Mesalazine—Tachycardia—Etoposide—brain cancer	0.000189	0.000661	CcSEcCtD
Mesalazine—Skin disorder—Etoposide—brain cancer	0.000189	0.000658	CcSEcCtD
Mesalazine—Hyperhidrosis—Etoposide—brain cancer	0.000188	0.000655	CcSEcCtD
Mesalazine—Anorexia—Etoposide—brain cancer	0.000185	0.000646	CcSEcCtD
Mesalazine—Hypersensitivity—Carmustine—brain cancer	0.000185	0.000646	CcSEcCtD
Mesalazine—Nausea—Hydroxyurea—brain cancer	0.000184	0.000644	CcSEcCtD
Mesalazine—Hypotension—Etoposide—brain cancer	0.000181	0.000633	CcSEcCtD
Mesalazine—Asthenia—Carmustine—brain cancer	0.00018	0.000629	CcSEcCtD
Mesalazine—Hypersensitivity—Temozolomide—brain cancer	0.000179	0.000624	CcSEcCtD
Mesalazine—Paraesthesia—Etoposide—brain cancer	0.000174	0.000609	CcSEcCtD
Mesalazine—Asthenia—Temozolomide—brain cancer	0.000174	0.000608	CcSEcCtD
Mesalazine—Dyspnoea—Etoposide—brain cancer	0.000173	0.000604	CcSEcCtD
Mesalazine—Somnolence—Etoposide—brain cancer	0.000173	0.000603	CcSEcCtD
Mesalazine—Diarrhoea—Carmustine—brain cancer	0.000172	0.0006	CcSEcCtD
Mesalazine—Pruritus—Temozolomide—brain cancer	0.000172	0.000599	CcSEcCtD
Mesalazine—Decreased appetite—Etoposide—brain cancer	0.000169	0.000589	CcSEcCtD
Mesalazine—Gastrointestinal disorder—Etoposide—brain cancer	0.000168	0.000585	CcSEcCtD
Mesalazine—Fatigue—Etoposide—brain cancer	0.000167	0.000584	CcSEcCtD
Mesalazine—Dizziness—Carmustine—brain cancer	0.000166	0.00058	CcSEcCtD
Mesalazine—Pain—Etoposide—brain cancer	0.000166	0.00058	CcSEcCtD
Mesalazine—Constipation—Etoposide—brain cancer	0.000166	0.00058	CcSEcCtD
Mesalazine—Diarrhoea—Temozolomide—brain cancer	0.000166	0.00058	CcSEcCtD
Mesalazine—Dizziness—Temozolomide—brain cancer	0.00016	0.00056	CcSEcCtD
Mesalazine—Feeling abnormal—Etoposide—brain cancer	0.00016	0.000558	CcSEcCtD
Mesalazine—Vomiting—Carmustine—brain cancer	0.00016	0.000557	CcSEcCtD
Mesalazine—Gastrointestinal pain—Etoposide—brain cancer	0.000159	0.000554	CcSEcCtD
Mesalazine—Rash—Carmustine—brain cancer	0.000158	0.000553	CcSEcCtD
Mesalazine—Dermatitis—Carmustine—brain cancer	0.000158	0.000552	CcSEcCtD
Mesalazine—Headache—Carmustine—brain cancer	0.000157	0.000549	CcSEcCtD
Mesalazine—Vomiting—Temozolomide—brain cancer	0.000154	0.000539	CcSEcCtD
Mesalazine—Urticaria—Etoposide—brain cancer	0.000154	0.000538	CcSEcCtD
Mesalazine—Abdominal pain—Etoposide—brain cancer	0.000153	0.000536	CcSEcCtD
Mesalazine—Body temperature increased—Etoposide—brain cancer	0.000153	0.000536	CcSEcCtD
Mesalazine—Rash—Temozolomide—brain cancer	0.000153	0.000534	CcSEcCtD
Mesalazine—Dermatitis—Temozolomide—brain cancer	0.000153	0.000534	CcSEcCtD
Mesalazine—Headache—Temozolomide—brain cancer	0.000152	0.000531	CcSEcCtD
Mesalazine—Nausea—Carmustine—brain cancer	0.000149	0.000521	CcSEcCtD
Mesalazine—Nausea—Temozolomide—brain cancer	0.000144	0.000503	CcSEcCtD
Mesalazine—Hypersensitivity—Etoposide—brain cancer	0.000143	0.000499	CcSEcCtD
Mesalazine—Asthenia—Etoposide—brain cancer	0.000139	0.000486	CcSEcCtD
Mesalazine—Pruritus—Etoposide—brain cancer	0.000137	0.00048	CcSEcCtD
Mesalazine—Diarrhoea—Etoposide—brain cancer	0.000133	0.000464	CcSEcCtD
Mesalazine—Dizziness—Etoposide—brain cancer	0.000128	0.000448	CcSEcCtD
Mesalazine—Vomiting—Etoposide—brain cancer	0.000123	0.000431	CcSEcCtD
Mesalazine—Rash—Etoposide—brain cancer	0.000122	0.000427	CcSEcCtD
Mesalazine—Dermatitis—Etoposide—brain cancer	0.000122	0.000427	CcSEcCtD
Mesalazine—Headache—Etoposide—brain cancer	0.000122	0.000425	CcSEcCtD
Mesalazine—Nausea—Etoposide—brain cancer	0.000115	0.000403	CcSEcCtD
Mesalazine—CHUK—BDNF signaling pathway—STAT3—brain cancer	0.000107	0.000624	CbGpPWpGaD
Mesalazine—IKBKB—Apoptosis Modulation and Signaling—TP53—brain cancer	0.000107	0.000623	CbGpPWpGaD
Mesalazine—PTGS2—Disease—DTX2—brain cancer	0.000106	0.000617	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—ERBB2—brain cancer	0.000105	0.000614	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000105	0.000612	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—VEGFA—brain cancer	0.000104	0.000607	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	0.000104	0.000604	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—ENO2—brain cancer	0.000101	0.000586	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—RELA—brain cancer	0.000101	0.000586	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—ERBB2—brain cancer	9.99e-05	0.000582	CbGpPWpGaD
Mesalazine—CHUK—Signaling by SCF-KIT—EGFR—brain cancer	9.9e-05	0.000577	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	9.89e-05	0.000577	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	9.84e-05	0.000573	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	9.8e-05	0.000571	CbGpPWpGaD
Mesalazine—CHUK—Downstream signal transduction—STAT3—brain cancer	9.79e-05	0.000571	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—HES1—brain cancer	9.73e-05	0.000567	CbGpPWpGaD
Mesalazine—IKBKB—BDNF signaling pathway—STAT3—brain cancer	9.71e-05	0.000566	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—MYC—brain cancer	9.58e-05	0.000558	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PTCH2—brain cancer	9.49e-05	0.000553	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling of activated FGFR—EGFR—brain cancer	9.47e-05	0.000552	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—VAV1—brain cancer	9.38e-05	0.000547	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—EGFR—brain cancer	9.37e-05	0.000546	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB4—EGFR—brain cancer	9.32e-05	0.000543	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HES5—brain cancer	9.19e-05	0.000536	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—BSG—brain cancer	9.16e-05	0.000534	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—STAT3—brain cancer	9.08e-05	0.000529	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	9.08e-05	0.000529	CbGpPWpGaD
Mesalazine—PTGS2—C-MYB transcription factor network—MYC—brain cancer	9.07e-05	0.000529	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—VAV1—brain cancer	9.01e-05	0.000525	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—STRADA—brain cancer	8.92e-05	0.00052	CbGpPWpGaD
Mesalazine—CHUK—Downstream signal transduction—EGFR—brain cancer	8.9e-05	0.000519	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—STAT3—brain cancer	8.88e-05	0.000517	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR—EGFR—brain cancer	8.86e-05	0.000516	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—IL2—brain cancer	8.84e-05	0.000515	CbGpPWpGaD
Mesalazine—CHUK—Disease—IDH1—brain cancer	8.83e-05	0.000515	CbGpPWpGaD
Mesalazine—CHUK—Signaling by ERBB2—EGFR—brain cancer	8.81e-05	0.000514	CbGpPWpGaD
Mesalazine—CHUK—DAP12 signaling—EGFR—brain cancer	8.77e-05	0.000511	CbGpPWpGaD
Mesalazine—CHUK—Downstream signaling events of B Cell Receptor (BCR)—EGFR—brain cancer	8.64e-05	0.000504	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	8.63e-05	0.000503	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—CCND1—brain cancer	8.62e-05	0.000502	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PTCH2—brain cancer	8.61e-05	0.000501	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—APC—brain cancer	8.54e-05	0.000498	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—VAV1—brain cancer	8.51e-05	0.000496	CbGpPWpGaD
Mesalazine—CHUK—Disease—HEY1—brain cancer	8.37e-05	0.000488	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HES5—brain cancer	8.33e-05	0.000486	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—RELA—brain cancer	8.3e-05	0.000484	CbGpPWpGaD
Mesalazine—CHUK—DAP12 interactions—EGFR—brain cancer	8.25e-05	0.000481	CbGpPWpGaD
Mesalazine—CHUK—Signaling by FGFR in disease—EGFR—brain cancer	8.25e-05	0.000481	CbGpPWpGaD
Mesalazine—CHUK—Fc epsilon receptor (FCERI) signaling—EGFR—brain cancer	8.25e-05	0.000481	CbGpPWpGaD
Mesalazine—CHUK—Disease—DLL1—brain cancer	8.21e-05	0.000478	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR—EGFR—brain cancer	8.18e-05	0.000476	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—VAV1—brain cancer	8.17e-05	0.000476	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—RELA—brain cancer	8.16e-05	0.000475	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—ERBB2—brain cancer	8.11e-05	0.000472	CbGpPWpGaD
Mesalazine—CHUK—Signaling by EGFR in Cancer—EGFR—brain cancer	8.1e-05	0.000472	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—STRADA—brain cancer	8.09e-05	0.000471	CbGpPWpGaD
Mesalazine—CHUK—Signaling by PDGF—EGFR—brain cancer	8.07e-05	0.00047	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—STAT3—brain cancer	8.04e-05	0.000469	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—MYC—brain cancer	7.97e-05	0.000465	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	7.94e-05	0.000462	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—IDH1—brain cancer	7.88e-05	0.000459	CbGpPWpGaD
Mesalazine—CHUK—Integrated Breast Cancer Pathway—TP53—brain cancer	7.87e-05	0.000458	CbGpPWpGaD
Mesalazine—IKBKB—Downstream signaling events of B Cell Receptor (BCR)—EGFR—brain cancer	7.84e-05	0.000457	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—EGFR—brain cancer	7.8e-05	0.000455	CbGpPWpGaD
Mesalazine—PTGS2—Disease—HES5—brain cancer	7.77e-05	0.000453	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	7.76e-05	0.000452	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—PDGFRA—brain cancer	7.68e-05	0.000448	CbGpPWpGaD
Mesalazine—CHUK—B Cell Activation—EGFR—brain cancer	7.63e-05	0.000445	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—CDK4—brain cancer	7.63e-05	0.000445	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—CYP2C9—brain cancer	7.55e-05	0.00044	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—RELA—brain cancer	7.53e-05	0.000439	CbGpPWpGaD
Mesalazine—IKBKB—Fc epsilon receptor (FCERI) signaling—EGFR—brain cancer	7.48e-05	0.000436	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—IL2—brain cancer	7.47e-05	0.000436	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—ABR—brain cancer	7.45e-05	0.000434	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—RELA—brain cancer	7.4e-05	0.000431	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—PDGFRA—brain cancer	7.38e-05	0.00043	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—ERBB2—brain cancer	7.35e-05	0.000428	CbGpPWpGaD
Mesalazine—CHUK—NGF signalling via TRKA from the plasma membrane—EGFR—brain cancer	7.31e-05	0.000426	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—GLI2—brain cancer	7.19e-05	0.000419	CbGpPWpGaD
Mesalazine—CHUK—Immune System—SKP2—brain cancer	7.17e-05	0.000418	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—DNMT1—brain cancer	7.14e-05	0.000416	CbGpPWpGaD
Mesalazine—CHUK—Disease—SHH—brain cancer	6.98e-05	0.000407	CbGpPWpGaD
Mesalazine—CHUK—Disease—ENO2—brain cancer	6.98e-05	0.000407	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—PDGFRA—brain cancer	6.97e-05	0.000406	CbGpPWpGaD
Mesalazine—IKBKB—B Cell Activation—EGFR—brain cancer	6.92e-05	0.000403	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—MYC—brain cancer	6.91e-05	0.000403	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—IL2—brain cancer	6.78e-05	0.000395	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—GLI1—brain cancer	6.76e-05	0.000394	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—EGFR—brain cancer	6.76e-05	0.000394	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—ABR—brain cancer	6.75e-05	0.000394	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—IRS2—brain cancer	6.74e-05	0.000393	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—PDGFRA—brain cancer	6.69e-05	0.00039	CbGpPWpGaD
Mesalazine—PPARG—Circadian rythm related genes—TP53—brain cancer	6.66e-05	0.000388	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	6.63e-05	0.000387	CbGpPWpGaD
Mesalazine—IKBKB—MAPK Signaling Pathway—TP53—brain cancer	6.55e-05	0.000382	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—GLI2—brain cancer	6.52e-05	0.00038	CbGpPWpGaD
Mesalazine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	6.52e-05	0.00038	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—SKP2—brain cancer	6.5e-05	0.000379	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—IRS2—brain cancer	6.48e-05	0.000377	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—BSG—brain cancer	6.42e-05	0.000374	CbGpPWpGaD
Mesalazine—PPARG—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	6.42e-05	0.000374	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—SUFU—brain cancer	6.41e-05	0.000374	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—ESR2—brain cancer	6.41e-05	0.000373	CbGpPWpGaD
Mesalazine—CHUK—Cytokine Signaling in Immune system—STAT3—brain cancer	6.29e-05	0.000367	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—ENO2—brain cancer	6.23e-05	0.000363	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—GFAP—brain cancer	6.18e-05	0.00036	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—STAT3—brain cancer	6.18e-05	0.00036	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—GLI1—brain cancer	6.13e-05	0.000357	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—IRS2—brain cancer	6.11e-05	0.000356	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—NOTCH2—brain cancer	6.07e-05	0.000354	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—CYP2C9—brain cancer	5.99e-05	0.000349	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—IRS2—brain cancer	5.87e-05	0.000342	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HEY1—brain cancer	5.86e-05	0.000342	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	5.86e-05	0.000342	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—SUFU—brain cancer	5.81e-05	0.000339	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	5.8e-05	0.000338	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—DLL1—brain cancer	5.75e-05	0.000335	CbGpPWpGaD
Mesalazine—IKBKB—Cytokine Signaling in Immune system—STAT3—brain cancer	5.7e-05	0.000332	CbGpPWpGaD
Mesalazine—PTGS2—Spinal Cord Injury—TP53—brain cancer	5.68e-05	0.000331	CbGpPWpGaD
Mesalazine—CHUK—Signaling by NGF—EGFR—brain cancer	5.62e-05	0.000328	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—RELA—brain cancer	5.61e-05	0.000327	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—GFAP—brain cancer	5.61e-05	0.000327	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—STAT3—brain cancer	5.61e-05	0.000327	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—ERBB2—brain cancer	5.58e-05	0.000325	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—IDH1—brain cancer	5.52e-05	0.000322	CbGpPWpGaD
Mesalazine—CHUK—Immune System—VAV1—brain cancer	5.46e-05	0.000318	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HEY1—brain cancer	5.32e-05	0.00031	CbGpPWpGaD
Mesalazine—PTGS2—Disease—IDH1—brain cancer	5.23e-05	0.000305	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—DLL1—brain cancer	5.21e-05	0.000304	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—SIRT1—brain cancer	5.16e-05	0.000301	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	5.11e-05	0.000298	CbGpPWpGaD
Mesalazine—IKBKB—Signaling by NGF—EGFR—brain cancer	5.1e-05	0.000297	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—BSG—brain cancer	5.1e-05	0.000297	CbGpPWpGaD
Mesalazine—CHUK—Disease—VAV1—brain cancer	5.04e-05	0.000294	CbGpPWpGaD
Mesalazine—PTGS2—Disease—HEY1—brain cancer	4.96e-05	0.000289	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—VAV1—brain cancer	4.95e-05	0.000289	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—SHH—brain cancer	4.89e-05	0.000285	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—CTNNB1—brain cancer	4.88e-05	0.000284	CbGpPWpGaD
Mesalazine—PTGS2—Disease—DLL1—brain cancer	4.86e-05	0.000283	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TRPC6—brain cancer	4.71e-05	0.000275	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	4.7e-05	0.000274	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—RELA—brain cancer	4.65e-05	0.000271	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—SMO—brain cancer	4.63e-05	0.00027	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PTCH1—brain cancer	4.63e-05	0.00027	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—ERBB2—brain cancer	4.62e-05	0.000269	CbGpPWpGaD
Mesalazine—ALOX5—Metabolism—PIK3CG—brain cancer	4.62e-05	0.000269	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	4.6e-05	0.000268	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	4.49e-05	0.000262	CbGpPWpGaD
Mesalazine—CHUK—Immune System—PDGFRA—brain cancer	4.47e-05	0.000261	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—RELA—brain cancer	4.47e-05	0.00026	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—ERBB2—brain cancer	4.44e-05	0.000259	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—SHH—brain cancer	4.43e-05	0.000258	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—IDH1—brain cancer	4.38e-05	0.000255	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—ENO2—brain cancer	4.36e-05	0.000254	CbGpPWpGaD
Mesalazine—CHUK—Disease—HES1—brain cancer	4.34e-05	0.000253	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—VEGFA—brain cancer	4.3e-05	0.00025	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TRPC6—brain cancer	4.27e-05	0.000249	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—STAT3—brain cancer	4.25e-05	0.000248	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—RELA—brain cancer	4.22e-05	0.000246	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—SMO—brain cancer	4.2e-05	0.000245	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PTCH1—brain cancer	4.2e-05	0.000245	CbGpPWpGaD
Mesalazine—PPARG—Generic Transcription Pathway—MYC—brain cancer	4.2e-05	0.000245	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—ERBB2—brain cancer	4.19e-05	0.000244	CbGpPWpGaD
Mesalazine—PTGS2—Disease—ENO2—brain cancer	4.14e-05	0.000241	CbGpPWpGaD
Mesalazine—PTGS2—Disease—SHH—brain cancer	4.14e-05	0.000241	CbGpPWpGaD
Mesalazine—CHUK—Disease—PDGFRA—brain cancer	4.13e-05	0.000241	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—PDGFRA—brain cancer	4.06e-05	0.000236	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—RELA—brain cancer	4.05e-05	0.000236	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—CTNNB1—brain cancer	4.05e-05	0.000236	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—ERBB2—brain cancer	4.03e-05	0.000235	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IRS2—brain cancer	3.93e-05	0.000229	CbGpPWpGaD
Mesalazine—PPARG—Developmental Biology—EGFR—brain cancer	3.87e-05	0.000225	CbGpPWpGaD
Mesalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	3.86e-05	0.000225	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—NOTCH2—brain cancer	3.71e-05	0.000216	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—CTNNB1—brain cancer	3.67e-05	0.000214	CbGpPWpGaD
Mesalazine—CHUK—Disease—IRS2—brain cancer	3.63e-05	0.000211	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.57e-05	0.000208	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IRS2—brain cancer	3.56e-05	0.000208	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—VAV1—brain cancer	3.53e-05	0.000206	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—ENO2—brain cancer	3.46e-05	0.000202	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—NOTCH2—brain cancer	3.36e-05	0.000196	CbGpPWpGaD
Mesalazine—CHUK—Innate Immune System—EGFR—brain cancer	3.21e-05	0.000187	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—VAV1—brain cancer	3.2e-05	0.000187	CbGpPWpGaD
Mesalazine—CHUK—Disease—APC—brain cancer	3.2e-05	0.000187	CbGpPWpGaD
Mesalazine—CHUK—Adaptive Immune System—EGFR—brain cancer	3.08e-05	0.000179	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—HES1—brain cancer	3.04e-05	0.000177	CbGpPWpGaD
Mesalazine—PTGS2—Disease—VAV1—brain cancer	2.99e-05	0.000174	CbGpPWpGaD
Mesalazine—IKBKB—Innate Immune System—EGFR—brain cancer	2.91e-05	0.000169	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PDGFRA—brain cancer	2.89e-05	0.000169	CbGpPWpGaD
Mesalazine—PPARG—Metabolism—PIK3CG—brain cancer	2.86e-05	0.000166	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—SPP1—brain cancer	2.81e-05	0.000164	CbGpPWpGaD
Mesalazine—IKBKB—Adaptive Immune System—EGFR—brain cancer	2.79e-05	0.000163	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—HES1—brain cancer	2.75e-05	0.000161	CbGpPWpGaD
Mesalazine—CHUK—Immune System—RELA—brain cancer	2.71e-05	0.000158	CbGpPWpGaD
Mesalazine—CHUK—Immune System—ERBB2—brain cancer	2.69e-05	0.000157	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PDGFRA—brain cancer	2.62e-05	0.000153	CbGpPWpGaD
Mesalazine—PTGS2—Disease—HES1—brain cancer	2.57e-05	0.00015	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—SPP1—brain cancer	2.55e-05	0.000148	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IRS2—brain cancer	2.54e-05	0.000148	CbGpPWpGaD
Mesalazine—CHUK—Disease—ERBB2—brain cancer	2.49e-05	0.000145	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—RELA—brain cancer	2.46e-05	0.000143	CbGpPWpGaD
Mesalazine—PTGS2—Disease—PDGFRA—brain cancer	2.45e-05	0.000143	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—ERBB2—brain cancer	2.44e-05	0.000142	CbGpPWpGaD
Mesalazine—CHUK—Immune System—IL2—brain cancer	2.44e-05	0.000142	CbGpPWpGaD
Mesalazine—CHUK—Immune System—CTNNB1—brain cancer	2.36e-05	0.000137	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IRS2—brain cancer	2.3e-05	0.000134	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—PIK3CG—brain cancer	2.24e-05	0.000131	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—APC—brain cancer	2.24e-05	0.000131	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—IL2—brain cancer	2.21e-05	0.000129	CbGpPWpGaD
Mesalazine—CHUK—Disease—CTNNB1—brain cancer	2.18e-05	0.000127	CbGpPWpGaD
Mesalazine—PTGS2—Disease—IRS2—brain cancer	2.15e-05	0.000125	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—CTNNB1—brain cancer	2.14e-05	0.000125	CbGpPWpGaD
Mesalazine—CHUK—Immune System—STAT3—brain cancer	2.05e-05	0.00012	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—APC—brain cancer	2.03e-05	0.000119	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—PIK3CG—brain cancer	2.03e-05	0.000119	CbGpPWpGaD
Mesalazine—PPARG—Gene Expression—MYC—brain cancer	2.02e-05	0.000118	CbGpPWpGaD
Mesalazine—PTGS1—Metabolism—PIK3CG—brain cancer	2e-05	0.000117	CbGpPWpGaD
Mesalazine—PTGS2—Disease—APC—brain cancer	1.9e-05	0.000111	CbGpPWpGaD
Mesalazine—CHUK—Disease—STAT3—brain cancer	1.9e-05	0.000111	CbGpPWpGaD
Mesalazine—CHUK—Immune System—EGFR—brain cancer	1.87e-05	0.000109	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—STAT3—brain cancer	1.86e-05	0.000109	CbGpPWpGaD
Mesalazine—CHUK—Disease—MYC—brain cancer	1.76e-05	0.000103	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—RELA—brain cancer	1.75e-05	0.000102	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—ERBB2—brain cancer	1.74e-05	0.000101	CbGpPWpGaD
Mesalazine—CHUK—Disease—EGFR—brain cancer	1.72e-05	0.0001	CbGpPWpGaD
Mesalazine—IKBKB—Immune System—EGFR—brain cancer	1.69e-05	9.87e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—RELA—brain cancer	1.59e-05	9.26e-05	CbGpPWpGaD
Mesalazine—PTGS2—Metabolism—PIK3CG—brain cancer	1.59e-05	9.26e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—ERBB2—brain cancer	1.58e-05	9.2e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—IL2—brain cancer	1.58e-05	9.2e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CCND1—brain cancer	1.54e-05	8.97e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—CTNNB1—brain cancer	1.52e-05	8.88e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—ERBB2—brain cancer	1.47e-05	8.58e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—IL2—brain cancer	1.43e-05	8.34e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CCND1—brain cancer	1.4e-05	8.13e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—CTNNB1—brain cancer	1.38e-05	8.05e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—VEGFA—brain cancer	1.34e-05	7.82e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—STAT3—brain cancer	1.33e-05	7.74e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—CTNNB1—brain cancer	1.29e-05	7.51e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—MYC—brain cancer	1.23e-05	7.19e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—VEGFA—brain cancer	1.22e-05	7.09e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—EGFR—brain cancer	1.21e-05	7.03e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—STAT3—brain cancer	1.2e-05	7.02e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—STAT3—brain cancer	1.12e-05	6.55e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—MYC—brain cancer	1.12e-05	6.52e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—EGFR—brain cancer	1.09e-05	6.38e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—MYC—brain cancer	1.04e-05	6.08e-05	CbGpPWpGaD
Mesalazine—PTGS2—Disease—EGFR—brain cancer	1.02e-05	5.95e-05	CbGpPWpGaD
Mesalazine—CHUK—Signaling Pathways—TP53—brain cancer	1.01e-05	5.91e-05	CbGpPWpGaD
Mesalazine—IKBKB—Signaling Pathways—TP53—brain cancer	9.19e-06	5.36e-05	CbGpPWpGaD
